Welcome to our dedicated page for Kopin SEC filings (Ticker: KOPN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kopin Corporation (NASDAQ: KOPN) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including registration statements, current reports and financial reports filed with the U.S. Securities and Exchange Commission. Kopin describes itself in these documents as a Delaware corporation, incorporated in 1984 and headquartered in Westborough, Massachusetts, focused on high-performance microdisplays and application-specific optical solutions for defense, enterprise, industrial, consumer and medical products.
Among the key filings, Kopin has submitted Form S-1 and S-1/A registration statements related to the resale of common stock issued in a private placement. These documents outline the terms of a PIPE financing, the number of shares registered for resale, the Nasdaq Capital Market listing under the symbol KOPN, and risk factor and business overview sections that describe its microdisplay portfolio, Application Specific Optical Solutions (ASOS), and global defense and industrial markets.
The company also files multiple Form 8-K current reports to disclose material events. Recent 8-Ks describe a $15 million strategic investment from Theon International Plc, including the issuance of Series A Convertible Preferred Stock and a 49% interest in Kopin Europe Ltd., agreements to co-develop military-grade displays and color MicroLED products, a $41 million private placement of common stock, litigation-related financing arrangements, and leadership and compensation changes. Another 8-K incorporates by reference quarterly financial results, which detail revenue by category (defense, industrial/enterprise, medical, research and development, and license and royalties), expenses and net income or loss.
On Stock Titan, these filings are updated in near real time from EDGAR and can be paired with AI-powered summaries that explain the significance of each document. Users can quickly understand how a new S-1, 8-K or other filing affects Kopin’s capital structure, strategic partnerships, litigation exposure or operating performance. Investors can also use the filings page to monitor developments related to preferred stock terms, registration rights agreements, licensing and collaboration agreements, and other contracts referenced in Kopin’s disclosures.
Kopin Corporation reported new equity awards to its CEO, Michael Andrew Murray, in a Form 4 filing. On January 5, 2026, he received 583,658 shares of common stock at a price of $0.00 per share under the Company’s 2020 Equity Incentive Plan. These shares will cliff vest in four years and are subject to plan restrictions.
On the same date, he was also granted a stock option for 724,638 shares of common stock with an exercise price of $3.21 per share, expiring on January 5, 2036. This option vests quarterly over four years from the grant date and is also issued under the 2020 Equity Incentive Plan. After these grants, he directly holds 3,157,789 shares of common stock and 1,316,004 derivative securities (options).
Kopin Corporation’s chief operating officer, Paul Christopher Baker, received a grant of 72,000 shares of common stock on January 5, 2026 at a stated price of $0.00 per share. These shares are restricted stock that vest over three years: 34% on December 10, 2026, 33% on December 10, 2027, and 33% on December 10, 2028, provided he continues to serve the company through each vesting date. The award was granted under Kopin’s 2020 Equity Incentive Plan. Following this grant, Baker directly beneficially owns 596,865 shares of Kopin common stock.
Kopin Corporation reported an insider share disposition tied to tax withholding. On December 10, 2025, a former executive officer transferred 20,606 shares of Kopin common stock at $2.66 per share, coded as an "F" transaction.
According to the filing, these shares were remitted back to Kopin as payment for taxes due when restrictions lapsed on a restricted common stock grant. After this transaction, the reporting person directly beneficially owned 610,277 Kopin shares.
Kopin Corporation disclosed an insider equity transaction by its CEO and director involving company common stock. On December 10, 2025, the insider disposed of 93,477 shares of Kopin common stock at $2.66 per share.
According to the footnote, these shares were remitted back to Kopin Corporation as payment for taxes due when restrictions lapsed on a restricted common stock grant. After this tax-withholding transaction, the insider beneficially owns 2,574,131 Kopin common shares in direct ownership.
Kopin Corporation has filed an amended Form S-1 to register up to 19,545,950 shares of common stock for resale by selling stockholders from a recent private placement.
The company is not issuing new shares in this offering and will not receive proceeds from these resales, though it previously raised an estimated $38.1 million of net proceeds in the PIPE at $2.10 per share. Before this resale, 184,755,629 shares of common stock are outstanding, based on 182,422,296 shares as of September 30, 2025 plus 2,333,333 shares issuable upon conversion of Series A preferred stock.
Recent developments include a $15.4 million U.S. defense award for MicroLED development, an approximate $9 million follow-on thermal imaging contract, and a $15 million strategic investment by Theon, including $7 million of Series A preferred stock convertible at $3.00 per share with a 4% annual dividend. Kopin also faces a $19.7 million litigation judgment under appeal, has posted a $23.0 million secured bond, carries a large accumulated deficit and recurring operating losses, and has identified material weaknesses in internal controls. The prospectus highlights significant risks from potential stock overhang, defense spending dependence, supply chain and geopolitical exposure, and high share-price volatility.
Kopin Corporation filed a Form S-8 to register 5,000,000 shares of common stock issuable under the Kopin Corporation 2020 Equity Incentive Plan.
Stockholders approved an amendment at the 2025 Annual Meeting on June 26, 2025 to authorize these additional shares. The filing uses General Instruction E to incorporate prior effective S-8 filings for the plan by reference and includes customary exhibits such as the legal opinion and auditor consents.
Kopin Corporation reported Q3 2025 results. Total revenue was $11.96 million versus $13.32 million a year ago, as lower research and development revenue offset steady defense-driven product sales. Operating income reached $4.53 million compared with a loss last year, primarily reflecting a $5.1 million litigation accrual reduction. Net income was $4.08 million (diluted EPS $0.02).
Year-to-date, revenue was $30.96 million versus $35.69 million and net loss narrowed to $4.20 million. Cash and cash equivalents were $26.51 million. The company ended the quarter with an accrued litigation liability of $19.7 million.
After quarter-end, Kopin posted a $23.0 million supersedeas bond related to the BlueRadios judgment, secured by a $24.2 million deposit classified as restricted cash. Remaining performance obligations totaled $39.1 million expected over the next 12 months. Shares outstanding were 182,513,346 as of November 12, 2025.
Kopin Corporation filed a current report to disclose that it issued a press release announcing its financial results for the third quarter ended September 27, 2025. The press release, dated November 12, 2025, is attached as an exhibit and provides the detailed results and commentary on the company’s operations during the quarter. The company notes that this earnings information is being furnished, rather than filed, which affects how it is treated under securities law.
Kopin Corporation filed a Form S-1 registering the resale by selling stockholders of up to 19,545,950 shares of common stock. These shares were issued in a September 29, 2025 private placement at $2.10 per share, and the company states it is not selling any securities and will not receive proceeds from stockholder sales.
Shares of common stock outstanding prior to this offering were 184,755,629. Kopin’s stock trades on Nasdaq as KOPN; the last reported sale price was $3.12 on November 5, 2025.
Recent activity includes approximate $38.1 million in net proceeds from the private placement, a $15.4 million U.S. defense award to advance MicroLED displays, and a strategic investment by Theon consisting of $8.0 million for 49% of Kopin Europe and $7.0 million of Series A Convertible Preferred Stock convertible at $3.00 per share with a 4% dividend and a forced-conversion trigger at $5.50. A post-trial order awarded approximately $19.7 million against the company; Kopin appealed and posted a $23.0 million bond.
Kopin Corporation (KOPN) reported an insider equity award on Form 4. Chief Financial Officer Mr. Manz acquired 400,000 shares of common stock on 09/02/2025 at $0.00, reported as a direct holding of 400,000 shares following the transaction.
The filing states these are restricted shares, with 25% vesting each December 10 beginning in 2026, conditioned on continued employment on each vesting date. The report notes it was filed late due to an administrative delay in obtaining EDGAR codes.